3,101
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Effects of green tea supplementation on inflammation markers, antioxidant status and blood pressure in NaCl-induced hypertensive rat model

, , , , , , , & show all
Article: 1295525 | Received 31 Aug 2016, Accepted 07 Feb 2017, Published online: 03 Mar 2017

References

  • Baszczuk A, Kopczyński Z, Degerowska P, et al. Assessment of laboratory markers of inflammation in patients with primary hypertension. Arterial Hypertens. 2011;15:251–6.
  • Guzik T. Role of immune system in arterial hypertension. Post N Med. 2011;3:36–45.
  • Głuszek T, Kosicka J. Is there arterial hypertension chronic inflammatory disease? Arterial Hypertens. 2011;15:363–370.
  • Hage FG. C-reactive protein and hypertension. J Hum Hypertens. 2014;28:410–415.
  • González J, Valls N, Brito R, et al. Essential hypertension and oxidative stress: new insights. World J Cardiol. 2014;6:353–366.
  • Harrison DG, Vinh A, Lob H, et al. Role of the adaptive immune system in hypertesion. Curr Opin Pharmacol. 2010;10:203–207.
  • Sesso HD, Buring JE, Rifai N, et al. C-reactive protein and risk of developing hypertension. Jama. 2003;290:2945–2951.
  • Galley HF, Thorton J, Howdle PD, et al. Combination oral antioxidant supplementataion reduces blood pressure. Clin Sci. 1997;92:361–365.
  • Satoh E, Tohyama N, Nishimura M. Comparison of the antioxidant activity of roasted tea with green, oolong and black teas. Iner J Food Sci Nutr. 2005;56:551–559.
  • Maciążek-Jurczyk M, Maliszewska M, Szkudlarek-Haśnik A, et al. Prevention action of green tea in coronary artery disease. Postępy Fizjoterapii. 2011;1:58–64.
  • Potenza MA, Marasciulo FL, Tarquinio M, et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protect against myocardial I/R injury in SHR. Am J Physiol Endocrinol Matab. 2007;292:1378–1387.
  • Negishi H, Xu JW, Ikeda K, et al. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr. 2004;134:38–42.
  • Ihm SH, Jang SW, Kim OR, et al. Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome. Atherosclerosis. 2012;224:377–383.
  • Bhardwaj P, Khanna D. Green tea catechins: defensive role in cardiovascular. Chin J Nat Med. 2013;11:345–353.
  • Zhang H, Park Y, Wu J, et al. Role of TNF-alfa in vascular dysfunction. Clin Sci. 2009;116:219–230.
  • Cao H, Kelly MA, Kari F, et al. Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm. 2007;5:1.
  • Chung MY, Mah E, Masterjohn C, et al. Green tea lowers hepatic COX-2 and prostaglandin E2 in rats with dietary fat-induced nonalcoholic steatohepatitis. J Med Food. 2015;18:648–655.
  • Li M, Liu JT, Pang XM, et al. Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages. Pharmacol Rep. 2012;64:912–918.
  • Yilmaz R, Akoglu H, Altun B, et al. Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients. Eur J Clin Nutr. 2012;66:1214–1218.
  • Riegsecker S, Wiczynski D, Kaplan MJ, et al. Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. Life Sci. 2013;93:307–312.
  • Cavet ME, Harrington KL, Vollmer TR, et al. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Mol Vis. 2011;18:533–542.
  • Wang ZM, Gao W, Wang H, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits TNF-α-induced production of monocyte chemoattractant protein-1 in human umbilical vein endothelial cells. Cell Physiol Biochem. 2014;33:1349–1358.
  • Choi KC, Jung MG, Lee YH, et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 2009;69:583–592.
  • Singh R, Akhtar N, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. Life Sci. 2010;86:907–918.
  • Surh YJ. NF-kB and AP-1 as molecular targets for chemoprevention with EGCG, a review. Environ Chem Lett. 2006;4:137–141.
  • Dobrzyńska I, Szachowicz-Petelska B, Ostrowska J, et al. Protective effect of green tea on erythrocyte membrane of different age rats intoxicated with ethanol. Chem Biol Interact. 2005;156:41–53.
  • Kager N, Ferk F, Kundi M, et al. Prevention of oxidative DNA damage in inner organs and lymphocytes of rats by green tea extract. Eur J Nutr. 2010;49:227–234.
  • Narotzki B, Reznick AZ, Mitki T, et al. Green tea drinking improves erythrocytes and saliva oxidative status in the elderly. Adv Exp Med Biol. 2015;832:25–33.
  • Bogdanski P, Suliburska J, Szulinska M, et al. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res. 2012;32:421–427.
  • Kim SJ, Jeong HJ, Lee KM, et al. Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. J Nutr Biochem. 2007;18:587–596.
  • Ezzati M, Lopez AD, Rodgers A, et al. Comparative Risk Assessment Collaborating Group. Selected major risk and global and regional burden of disease. Lancet. 2002;360:1347–1360.
  • Thielecke F, Boschmann M. The potencial role of green tea catechins in the prevention of the metabolic syndrome - a review. Phytochem. 2009;70:11–24.
  • Hakim IA, Chow HH, Harris RB. Green tea consumption is associated with decreased DNA damage among GSTM1-positive smokers regardless of their hOGG1 genotype. J Nutr. 2008;138:1567–1571.
  • Frei B, Higdon JV. Antioxidants acitivity of tea polyphenols in vivo: evidence from animal studies. J Nutr. 2003;133:3275–3284.
  • Schewe T, Steffen Y, Sies H. How do dietary flavonoides improve vascular function? apositive paper. Arch Biochem Biophys. 2008;476:102–106.